Association between symptoms and objective physiological outcomes in severe COVID-19 pneumonia survivors
P. Zamani (London, United Kingdom), S. Mehrotra (London, United Kingdom), R. D'Cruz (London, United Kingdom), S. Mathew (London, United Kingdom), A. Byrne (London, United Kingdom), M. Choudhury (London, United Kingdom), T. Fleming (London, United Kingdom), S. Norton (London, United Kingdom), S. Birring (London, United Kingdom), A. Patel (London, United Kingdom), I. Patel (London, United Kingdom), F. Perrin (London, United Kingdom), M. Waller (London, United Kingdom), C. Jolley (London, United Kingdom)
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Zamani (London, United Kingdom), S. Mehrotra (London, United Kingdom), R. D'Cruz (London, United Kingdom), S. Mathew (London, United Kingdom), A. Byrne (London, United Kingdom), M. Choudhury (London, United Kingdom), T. Fleming (London, United Kingdom), S. Norton (London, United Kingdom), S. Birring (London, United Kingdom), A. Patel (London, United Kingdom), I. Patel (London, United Kingdom), F. Perrin (London, United Kingdom), M. Waller (London, United Kingdom), C. Jolley (London, United Kingdom). Association between symptoms and objective physiological outcomes in severe COVID-19 pneumonia survivors. 4051
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Clinical signs and symptoms as predictors of pneumonia in hospitalized children Source: Annual Congress 2008 - Miscellaneous respiratory infections Year: 2008
Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study Source: Eur Respir J, 58 (6) 2004474; 10.1183/13993003.04474-2020 Year: 2021
Clinical characteristics and burden of illness in a cohort of severe asthma patients Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021
Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Comparison of severity scores to predict outcomes in elderly patients with community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015
Clinical characteristics and outcome of patients with acute hypercapnic respiratory failure from a developing country Source: Eur Respir J 2004; 24: Suppl. 48, 542s Year: 2004
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
Clinical characteristics and outcomes of hospitalized COVID-19 pneumonia : impact of gender Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19 Year: 2021
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Community acquired pneumonia in patients with neuromuscular disorders. Severity assessment and outcome Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Evaluation of severity, inflammatory response and adherence to treatment guidelines impact on community-acquired pneumonia outcomes Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Health status measurement in COPD patients. Correlations with dyspnea and physiologic outcomes Source: Eur Respir J 2005; 26: Suppl. 49, 515s Year: 2005
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015
Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases Year: 2016
Clinical characteristics and symptoms in older and younger patients with community acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008